FOMAT is enrolling participants for EBV Vaccine Trial.

This Clinical Trial is being conducted to evaluate an investigational vaccine in participants from 18 to 30 years old during 18 months; in pursuit of a preventive method against Epstein-Barr Virus (EBV). Currently, there’s no vaccine for EBV.

Epstein-Barr Virus (EBV) is a human herpes virus, one of the most common human viruses which causes Infectious Mononucleosis, commonly known as “Mono”. It has also been linked to many other diseases.